It’s about timing, but not just timing. You might manage to wing it, but it is easy to fail. The small details might be small, but they are challenging. They test our patience, our concentration, and our ability to handle stress. There are countless little details, discover one only to realize it’s the tip of the iceberg.
Diagnostic likelihood, the compound, the isotope, the route it takes, the healing it brings, matching the treatment to the patient. Countless little details make the whole, make health whole, make life whole.
At Isotopia, we believe the difference between the strong and the weak is in the ability to keep the little details in sight. Don’t break. Don’t cut corners, Don’t sacrifice the details to try to capture the big picture. Because it won’t be whole, it will be incomplete. That is simply how we are at Isotopia.
We see the little flaws and we correct them, always leaning on the little details to aim for perfection. We grasp the details and the destination together. The whole picture. That is our passion, and that is how we believe health and life should be managed.
Isotopia Molecular Imaging Ltd. is a collaboration between The Metrontario Group and some of Israel’s leading scientists in the field of radiopharmaceuticals.
Actively involved in Isotopia are highly experienced and renowned experts in the area of Nuclear Medicine and Molecular Imaging. The team includes Radiopharmacists, Nuclear Engineers, Chemists, Technicians and logistics experts.
In our state of the art facility we produce short lived PET and SPECT radiopharmaceuticals . We implement the highest level of isotope production methods, radiochemical synthesis, purification, and quality control.
Isotopia uses our own logistics teams, certified by the competent authorities for preparing the doses in the safest and most practical method for delivery to your facility.
Our radiopharmaceutical production quality assurance system ensures that we deliver a quality dose, in compliance with the requirements of the health authorities, coupled with safety measures and on-time delivery.
We are interested in collaboration with the medical & scientific community to further develop and trial new markers in molecular imaging.